Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 7969 - 7976 of 12091 results

E-Cigarette Makers Contending with New CPSC and FDA Regulations
August 1, 2016| Blog| Viewpoint

California Wrestles with Challenges to Meet the State’s Renewable Energy Goals
August 1, 2016| Blog| Viewpoint

FTC Plants A Flag With LabMD Ruling: What This Means for Enforcement
August 1, 2016| Blog| Viewpoint

"Privacy Shield" Open For Business - Fees?
August 1, 2016| Blog| Viewpoint

OIG Gives Green Light to Hospice Provider’s Payment to Nursing Facilities
August 1, 2016| Blog| Viewpoint

Ninth Circuit Provides Clarification Concerning the Definition of Trade Secret
August 1, 2016| Blog| Viewpoint

The FDA issues preliminary guidance on 3D printing
August 1, 2016| News

Higher Immigration Penalties for I-9 and Other Violations Going Into Effect August 1, 2016
July 29, 2016| Alert| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
